ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years
Yuanyang Wang
Matched on OpenAlex author ID A5139500976. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2025: 2 papers · 2026: 2 papers
Papers 4
- TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated DNA damage repair and IRS2 expression i… Co-author DOI 10.1016/j.canlet.2026.218725↗
- Integrated scRNA-Seq and functional profiling reveal CD52 as a driver of pancreatic ductal adenocarcinoma metastasis and immunosuppression. Co-author DOI 10.1038/s41389-026-00637-x↗
- RNA binding protein Pumilio2 promotes chemoresistance of pancreatic cancer via focal adhesion pathway and interacting with transcription factor EGR1. Co-author DOI 10.1007/s00018-025-05599-8↗
- Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating VEGFA. Co-author DOI 10.7150/jca.110659↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Weibin Wang · 2 shared papers, 2025 · strength 0.54
- Paper RNA binding protein Pumilio2 promotes chemoresistance of pancreatic cancer via focal adhesion pathway and interacting w… DOI 10.1007/s00018-025-05599-8↗
- Paper Extracellular vesicles-miR-205-5p inhibits lymphatic metastasis in pancreatic cancer through diffusely downregulating V… DOI 10.7150/jca.110659↗
- Yifan Fu · 2 shared papers, 2026 · strength 0.49
- Paper Integrated scRNA-Seq and functional profiling reveal CD52 as a driver of pancreatic ductal adenocarcinoma metastasis an… DOI 10.1038/s41389-026-00637-x↗
- Paper TRDMT1-mediated mRNA m5C methylation decreases chemotherapy sensitivity by activating homologous recombination-mediated… DOI 10.1016/j.canlet.2026.218725↗
- Bangbo Zhao · 1 shared paper, 2025 · strength 0.27
- Zhao Bangbo · 1 shared paper, 2025 · strength 0.27
- Zhao Yu-Pei · 1 shared paper, 2025 · strength 0.27
- Yutong Zhao · 1 shared paper, 2025 · strength 0.27
- Cheng Yong Qin · 1 shared paper, 2025 · strength 0.27
- Tianyu Li · 1 shared paper, 2025 · strength 0.27
- Zeru Li · 1 shared paper, 2025 · strength 0.27
- Jinxin Tao · 1 shared paper, 2026 · strength 0.25
- Zeyu Zhang · 1 shared paper, 2026 · strength 0.25
- Zhe Cao · 1 shared paper, 2026 · strength 0.25
- Taiping Zhang · 1 shared paper, 2026 · strength 0.25
- Zhe Cao · 1 shared paper, 2026 · strength 0.24
- Yupei Zhao · 1 shared paper, 2026 · strength 0.24
- Jianchun Xiao · 1 shared paper, 2026 · strength 0.24
- Yueze Liu · 1 shared paper, 2026 · strength 0.24
- Wenhao Luo · 1 shared paper, 2026 · strength 0.24
- Lei You · 1 shared paper, 2026 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.